Literature DB >> 6268576

Dosimetry of 131I-labeled anti-ferritin in hepatoma: a model for radioimmunoglobulin dosimetry.

P K Leichner, J L Klein, J B Garrison, R E Jenkins, E L Nickoloff, D S Ettinger, S E Order.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268576     DOI: 10.1016/0360-3016(81)90105-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  6 in total

Review 1.  A role for gamma scintigraphy in cancer immunology and immunotherapy.

Authors:  A C Perkins; M V Pimm
Journal:  Eur J Nucl Med       Date:  1992

2.  Accurate quantification of 131I distribution by gamma camera imaging.

Authors:  A J Green; S E Dewhurst; R H Begent; K D Bagshawe; S J Riggs
Journal:  Eur J Nucl Med       Date:  1990

Review 3.  Radio-immunotherapy dosimetry with special emphasis on SPECT quantification and extracorporeal immuno-adsorption.

Authors:  S E Strand; M Ljungberg; J Tennvall; K Norrgren; M Garkavij
Journal:  Med Biol Eng Comput       Date:  1994-09       Impact factor: 2.602

4.  Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

Authors:  S M Larson; J A Carrasquillo; K A Krohn; J P Brown; R W McGuffin; J M Ferens; M M Graham; L D Hill; P L Beaumier; K E Hellström
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

5.  Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution.

Authors:  Y Yumoto; K Jinno; S Inatsuki; S Moriwaki; T Hanafusa; E Yumoto; T Shiota; T Higashi; N Koide; H Hada
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer.

Authors:  R H Begent; J A Ledermann; A J Green; K D Bagshawe; S J Riggs; F Searle; P A Keep; T Adam; R G Dale; M G Glaser
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.